AbCellera Biologics (ABCL) Other financing activities (2020 - 2024)
AbCellera Biologics (ABCL) posted Other financing activities of $227000.0 for Q3 2024, down 50.76% on a QoQ basis from $461000.0 in Q2 2024, and down 11.33% year-over-year from $256000.0 in Q4 2023.
AbCellera Biologics (ABCL) Other financing activities (2020 - 2024) Analysis & Trends
AbCellera Biologics' Other financing activities history runs 4 years deep, the most recent figure standing at $227000.0 for Q3 2024.
- Quarterly Other financing activities fell 11.33% year-over-year to $227000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $1.8 million (down 36.99% YoY) and the FY2021 annual result came in at $4.6 million, up 361.5% from the prior year.
- Other financing activities was $227000.0 for Q3 2024 at AbCellera Biologics, down from $461000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1.8 million in Q4 2021 and bottomed at -$548000.0 in Q2 2020.
- A 4-year average of $591071.4 and a median of $475500.0 in 2023 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 1614.02% in 2021, while the deepest fall reached 78.35% in 2021.
- AbCellera Biologics' Other financing activities stood at $107000.0 in 2020, then soared by 1614.02% to $1.8 million in 2021, then tumbled by 86.04% to $256000.0 in 2023, then retreated by 11.33% to $227000.0 in 2024.
- Business Quant data shows ABCL's Other financing activities at $227000.0 in Q3 2024, $461000.0 in Q2 2024, and $892000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 227,000.00 |
| Sep 30, 2024 | 227,000.00 |
| Jun 30, 2024 | 461,000.00 |
| Jun 30, 2024 | 461,000.00 |
| Mar 31, 2024 | 892,000.00 |
| Mar 31, 2024 | 892,000.00 |
| Sep 30, 2023 | 256,000.00 |
| Sep 30, 2023 | 256,000.00 |
| Jun 30, 2023 | 334,000.00 |
| Jun 30, 2023 | 334,000.00 |
| Mar 31, 2023 | 490,000.00 |
| Mar 31, 2023 | 490,000.00 |
| Dec 31, 2021 | 1.83 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 898,000.00 |
| Sep 30, 2021 | 898,000.00 |
| Jun 30, 2021 | 1.71 Mn |
| Jun 30, 2021 | 1.71 Mn |
| Mar 31, 2021 | 173,000.00 |
| Mar 31, 2021 | 173,000.00 |